Afuco™ Anti-Human FZD10 ADCC Therapeutic Antibody (OTSA101), ADCC Enhanced
Anti-FZD10 ADCC Enhanced Antibody (OTSA101) is an ADCC enhanced antibody produced by our Afuco™ platform. OTSA101 is an antibody drug targets a novel tumor-specific antigen FZD10 (Frizzled homolog 10), used for cancer therapy, has conducted phase I clinical trial for synovial sarcoma, which is a type of soft tissue sarcoma.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-282CL |
| Pricing | Inquiry |
| Host | Chimeric undefined source |
| Target | FZD10 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage |
|